Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|July 21, 1999
Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracilS Takatori, H Kanda, K Takenaka, et al.
Scandinavian Journal of Immunology|April 28, 2005
A sero-epidemiological survey of gelatin sensitization in young Japanese children during the 1979-1996 periodA Saito, T Kumagai, H Kojima, et al.
Cancer Research|February 15, 1989
Imbalance of deoxyribonucleoside triphosphates, DNA double-strand breaks, and cell death caused by 2-chlorodeoxyadenosine in mouse FM3A cellsY Hirota, A Yoshioka, S Tanaka, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Antitumor activity of FTC-092, a masked 5-trifluoromethyl-2'-deoxyuridine derivativeS Takeda, J Yamashita, H Saito, et al.
Nucleic Acids Symposium Series|January 1, 1991
DNA diagnosis of falciparum malariaY Wataya, F Kubochi, C Mizukoshi, et al.
The Journal of Biological Chemistry|June 15, 1987
Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell deathA Yoshioka, S Tanaka, O Hiraoka, et al.
Nucleic Acids Symposium Series|January 1, 1980
Use of alpha-secondary isotope effects in nucleophile-promoted reactions of pyrimidine derivatives; evidence for transient 5,6-dihydropyrimidine intermediatesY Wataya, R Kawada, A Itadani, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Potentiation of the antitumor activity of 5-trifluoromethyl-2'-deoxyuridine by the use of depot forms of the parent compoundS Takeda, K Wierzba, J Yamashita, et al.
Vaccine|April 20, 2001
A strong association between HLA-DR9 and gelatin allergy in the Japanese populationT Kumagai, T Yamanaka, Y Wataya, et al.
Japanese Journal of Cancer Research : Gann|June 1, 1992
Imbalance of deoxyribonucleoside triphosphates and DNA double-strand breaks in mouse mammary tumor FM3A cells treated in vitro with an antineoplastic tropolone derivativeM Yamato, Y Hirota, S Yoshida, et al.
Pageof 9